Jaguar Health, Inc. (JAGX)
Jaguar Health, Inc. (JAGX) is a biopharmaceutical company that focuses on developing and commercializing innovative oral plant-based medicines for animals and humans. The company emphasizes treatments derived from natural sources, particularly for gastrointestinal conditions, with a focus on products for veterinary and gastrointestinal health markets.
Company News
Toronto Star celebrates TIFF's 50th anniversary with a collector's edition magazine and photo exhibit featuring 50 iconic photographs by George Pimentel, highlighting the festival's cinematic history and star-studded moments.
Jaguar Health shares are falling after the company announced its phase 3 OnTarget trial results for crofelemer did not meet its primary endpoint. The stock has a float of only 4.889 million shares after a 1-for-60 reverse split.
Jaguar Health, a pharmaceutical company, has issued 455,000 shares of common stock to reduce its outstanding royalty balance by $1.85 million. This move is part of the company's strategy to manage its financial liabilities and streamline its capital structure.
Here's what you need to know about buying tech penny stocks in 2024 The post Picking Energy Penny Stocks, 3 Tips to Use appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.